Theravance licenses antibiotic tech to Hospira
(Reuters) - Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc. The company would purchase from Hospira more than a majority of its Vibativ 750 mg dosage form requirements during the five-year agreement, Theravance said in a regulatory filing. Vibativ is approved in Europe for the treatment of adults with nosocomial pneumonia and for bacterial skin infections in the United States and Canada. ...
Source: news.yahoo.com
No comments:
Post a Comment